4-(2-((5-(4-Chlorophenyl)-4-methyl-1H-pyrazol-3-yl)oxy)ethyl)morpholin e monohydrochloride

Suppliers

Names

[ Name ]:
4-(2-((5-(4-Chlorophenyl)-4-methyl-1H-pyrazol-3-yl)oxy)ethyl)morpholin e monohydrochloride

[Synonym ]:
Morpholine,4-(2-((5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl)oxy)ethyl)-,monohydrochloride
4-[2-[[5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride
4-(2-((5-(4-Chlorophenyl)-4-methyl-1H-pyrazol-3-yl)oxy)ethyl)morpholine monohydrochloride

Chemical & Physical Properties

[ Boiling Point ]:
502.3ºC at 760 mmHg

[ Molecular Formula ]:
C₁₆H₂₁Cl₂N₃O₂

[ Molecular Weight ]:
358.26300

[ Flash Point ]:
257.6ºC

[ Exact Mass ]:
357.10100

[ PSA ]:
50.38000

[ LogP ]:
3.48940

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: QE0479590

CHEMICAL NAME :: Morpholine, 4-(2-((5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl)ox y)ethyl)-, monohydrochloride

CAS REGISTRY NUMBER :: 86871-73-0

LAST UPDATED :: 199612

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C16-H20-Cl-N3-O2.Cl-H

MOLECULAR WEIGHT :: 358.30

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 500 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0076756

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 125 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0076756

Related Compounds

{3-Iodobicyclo[1.1.1]pentan-1-yl}methanesulfonyl fluoride
{7-Oxaspiro[3.5]nonan-6-yl}methanesulfonyl fluoride
1-[5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanoyl]azetidine-3-carboxylic acid
(1rs&,3rs&)-3-[(2RS,3SR)-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)oxolane-2-amido]cyclobutane-1-carboxylic acid
4-{3-[benzyl(methyl)amino]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido}-3-ethoxybutanoic acid
2-{3-[benzyl(methyl)amino]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido}-2-(methoxymethyl)butanoic acid
4-{[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methyloxolan-3-yl]formamido}-2-methoxybutanoic acid
4-{2-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-4-methylpentanamido}-2-methoxybutanoic acid
4-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2,2,3-trimethylbutanamido]-2-methoxybutanoic acid
rac-3-{[(1R,2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cycloheptyl]formamido}-2-methoxypropanoic acid

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.